Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Respiratory Sleep Solutions is a specialized healthcare provider focused on the diagnosis and management of sleep-disordered breathing and chronic respiratory diseases. The company provides comprehensive services including home-based sleep apnea testing, Continuous Positive Airway Pressure (CPAP) therapy, and ongoing clinical support for patients. By integrating medical equipment provision with clinical oversight, the company facilitates effective treatment pathways for conditions such as obstructive sleep apnea and COPD. In 2012, the company was acquired by Air Liquide Healthcare, a division of the global industrial gas giant Air Liquide, significantly expanding its operational capacity and service reach within the Australian healthcare market. Today, it operates as a key brand within the Air Liquide portfolio, leveraging extensive resources to provide high-quality respiratory care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Respiratory Sleep Solutions.